Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New lens offers sharper sight at all distances for cataract patients

NCT ID NCT06377514

Symptom relief Sponsor: Johnson & Johnson Surgical Vision, Inc. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Aug 25, 2026 · Updated 3 times

Summary

This study tested a new type of artificial lens (TECNIS Next-Generation) in 245 adults with cataracts in both eyes. The goal was to see if the new lens provides better vision at intermediate and near distances compared to a standard lens. Participants received the lens during routine cataract surgery and were followed for 6 months.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

245 people

The number who actually took part.

Started

Jun 2024

Finished

Apr 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

22 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

INCLUSION CRITERIA To be considered for enrollment in this study, patient must: * be at least 22 years old * have cataracts in both eyes * sign the written informed consent * be willing and able to comply with examination procedures * understand, read and write English to complete informed consent and questionnaires * be available for study follow-up visits EXCLUSION CRITERIA Patient will not be eligible to take part in the study if: * currently participating in any other clinical study or have participated in a clinical study during the last 30 days * have a certain disease/illness, such as poorly controlled diabetes * have certain ocular conditions, such as uncontrolled pressure in the eye * taking medication that may affect vision * pregnant, plan to become pregnant during the study, or are breastfeeding

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cataracts are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cataract

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cataracts

Contacts and locations

Locations

  • Berkeley Eye Institute

    Houston, Texas, 77027, United States

  • Cleveland Eye Clinic

    Brecksville, Ohio, 44141, United States

  • Empire Eye & Laser Center

    Bakersfield, California, 93309, United States

  • Jones Eye Center

    Sioux City, Iowa, 51104, United States

  • Levenson Eye Associates

    Jacksonville, Florida, 32204, United States

  • OCLI Vision

    Garden City, New York, 11530, United States

  • Parkhurst NuVision

    San Antonio, Texas, 78229, United States

  • Vance Thompson Vision

    Sioux Falls, South Dakota, 57108, United States

  • Whitsett Vision Group

    Houston, Texas, 77055, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.